The acquisition of malignant potential in colon cancer is regulated by the stabilization of Atonal homolog 1 protein

Biochemical and Biophysical Research Communications

Volumn 432, Issue 1, 2013, Pages 175-181

  Kano, Yoshihito ^a   Tsuchiya, Kiichiro ^a   Zheng, Xiu ^a   Horita, Nobukatsu ^a   Fukushima, Keita ^a   Hibiya, Shuji ^a   Yamauchi, Yuhki ^a   Nishimura, Tatsunori ^b   Hinohara, Kunihiko ^b   Gotoh, Noriko ^b   Suzuki, Shinji ^a,c   Okamoto, Ryuichi ^a   Nakamura, Tetsuya ^a   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c International University of Health and Welfare Mita Hospital   (Japan)

Author keywords

Atoh1; Cancer stem cell; Chemoresistance; Lgr5; Mucinous cancer

Indexed keywords

ATONAL HOMOLOG 1 PROTEIN; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; COLON CANCER; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UBIQUITINATION; WNT SIGNALING PATHWAY;

ADENOCARCINOMA, MUCINOUS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASTIC STEM CELLS; PROTEIN STABILITY; RECEPTORS, G-PROTEIN-COUPLED; WNT SIGNALING PATHWAY;

EID: 84875364286     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.01.034     Document Type: Article

References (21)

1. Jass J.R., Morson B.C. Reporting colorectal cancer. J. Clin. Pathol. 1987, 40:1016-1023.
2. Yang Q., Bermingham N.A., Finegold M.J., Zoghbi H.Y. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001, 294:2155-2158.
3. Leow C.C., Romero M.S., Ross S., Polakis P., Gao W.Q. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells. Cancer Res. 2004, 64:6050-6057.
4. Tsuchiya K., Nakamura T., Okamoto R., Kanai T., Watanabe M. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3 beta in human colon cancer. Gastroenterology 2007, 132:208-220.
5. Park E.T., Oh H.K., Gum J.R., Crawley S.C., Kakar S., Engel J., Leow C.C., Gao W.Q., Kim Y.S. HATH1 expression in mucinous cancers of the colorectum and related lesions. Clin. Cancer Res. 2006, 12:5403-5410.
6. Ayrault O., Zhao H., Zindy F., Qu C., Sherr C.J., Roussel M.F. Atoh1 inhibits neuronal differentiation and collaborates with Gli1 to generate medulloblastoma-initiating cells. Cancer Res. 2010, 70:5618-5627.
7. Bossuyt W., Kazanjian A., De Geest N., Van Kelst S., De Hertogh G., Geboes K., Boivin G.P., Luciani J., Fuks F., Chuah M., VandenDriessche T., Marynen P., Cools J., Shroyer N.F., Hassan B.A. Atonal homolog 1 is a tumor suppressor gene. PLoS Biol. 2009, 7:e39.
8. Aragaki M., Tsuchiya K., Okamoto R., Yoshioka S., Nakamura T., Sakamoto N., Kanai T., Watanabe M. Proteasomal degradation of Atoh1 by aberrant Wnt signaling maintains the undifferentiated state of colon cancer. Biochem. Biophys. Res. Commun. 2008, 368:923-929.
9. Zheng X., Tsuchiya K., Okamoto R., Iwasaki M., Kano Y., Sakamoto N., Nakamura T., Watanabe M. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis. Inflamm. Bowel Dis. 2011, 17:2251-2260.
10. Kobayashi S., Yamada-Okabe H., Suzuki M., Natori O., Kato A., Matsubara K., Jau Chen Y., Yamazaki M., Funahashi S., Yoshida K., Hashimoto E., Watanabe Y., Mutoh H., Ashihara M., Kato C., Watanabe T., Yoshikubo T., Tamaoki N., Ochiya T., Kuroda M., Levine A.J., Yamazaki T. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution. Stem Cells 2012, 30:2631-2644.
11. Hu Y., Smyth G.K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J. Immunol. Methods 2009, 347:70-78.
12. Sakaue-Sawano A., Kurokawa H., Morimura T., Hanyu A., Hama H., Osawa H., Kashiwagi S., Fukami K., Miyata T., Miyoshi H., Imamura T., Ogawa M., Masai H., Miyawaki A. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 2008, 132:487-498.
13. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:U1001-U1003.
14. Kemper K., Prasetyanti P.R., de Lau W., Rodermond H., Clevers H., Medema J.P. Monoclonal antibodies against lgr5 identify human colorectal cancer stem cells. Stem Cells 2012, 30:2378-2386.
15. Leushacke M., Barker N. Lgr5 and Lgr6 as markers to study adult stem cell roles in self-renewal and cancer. Oncogene 2011, 31:3009-3022.
16. Schepers A.G., Snippert H.J., Stange D.E., van den Born M., van Es J.H., van de Wetering M., Clevers H. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
17. Sancho E., Batlle E., Clevers H. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol. 2004, 20:695-723.
18. Kazanjian A., Shroyer N.F. NOTCH signaling and ATOH1 in colorectal cancers. Curr. Colorectal Cancer Rep. 2011, 7:121-127.
19. Moore N., Lyle S. Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J. Oncol. 2011, 2011. 10.1155/2011/396076.
20. Bozko P., Sabisz M., Larsen A.K., Skladanowski A. Cross-talk between DNA damage and cell survival checkpoints during G2 and mitosis: pharmacologic implications. Mol. Cancer Ther. 2005, 4:2016-2025.
21. Kessenbrock K., Plaks V., Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.